GPT and neoplasm: Our results revealed that Kdm6a liver‐specific knockout (Kdm6a CKO) mice displayed a lower serum alanine transaminase (ALT) activity, fewer tumours and a lower tumour burden than wild‐type (WT) mice (Figure 3B–E).